Comparing Treatments of Alcoholism on Craving and Biochemical Measures of Alcohol Consumptions
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
An open randomized study was conducted to compare different treatments of alcoholism on ethanol intake, craving, and on biochemical measures of alcohol consumptions. Eighty-six alcoholics were abstinent for a mean of two weeks prior to random assignment to g-hydroxybutyrate (GHB, 50 mg/kg of body weight t.i.d), naltrexone (NTX, 50 mg/day) or disulfiram (DSF, 200 mg/ day) treatment for 12 months. All treatments were equally effective in reducing alcohol intake and in maintaining abstinence. In all patients, the treatments were able to reduce both craving and the altered biological markers of alcohol abuse. The maximum effects were observed in GHB-treated patients. The results of the present study suggest that GHB might act both as anticraving and cellular protector agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rao, R. K., Seth, A., & Sheth, P. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00006.2004 · Cited by 340
Alcoholic liver disease: New insights in pathogenesis lead to new treatments
Lieber, C. S. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80420-1 · Cited by 260
Research works printed but not linked: 37
- 10.1006/bbrc.2001.5870 · DOI
- 10.1016/S1521-6918(03)00053-2 · DOI
- 10.1016/S0741-8329(01)00201-4 · DOI
- 10.2165/00002018-199615040-00005 · DOI
- 10.1111/j.1600-0447.1992.tb03316.x · DOI
- 10.1111/j.1530-0277.2002.tb02621.x · doi:10.1111/j.1530-0277.2002.tb02621.x · Paper page
- 10.2165/00002018-199920050-00003 · DOI · Paper page
- 10.1046/j.1359-6357.2003.00581.x · DOI · Paper page
- Diamond I., 1994, Western Journal of Medicine, 161, 279
- 10.1016/S0741-8329(02)00229-X · DOI
- 10.1179/016164103101202138 · doi:10.1179/016164103101202138
- 10.1152/ajpgi.00094.2004 · DOI · Paper page
- 10.1007/s11894-004-0027-0 · DOI
- 10.1016/S0369-8114(01)00239-5 · DOI
- 10.1080/10550490150504128 · DOI
- 10.1111/j.1530-0277.1999.tb04209.x · DOI
- 10.1056/NEJM199510193331607 · DOI · Paper page
- 10.1111/j.1530-0277.1997.tb03776.x · doi:10.1111/j.1530-0277.1997.tb03776.x
- 10.1016/S0149-7634(89)80053-3 · DOI · Paper page
- 10.2165/00023210-200418080-00002 · DOI · Paper page
- 10.1152/ajpgi.00171.2004 · DOI · Paper page
- 10.1517/14656566.5.10.2075 · DOI
- 10.1292/jvms.63.275 · DOI
- Okun M. S., 2001, Journal of Pharmacy and Pharmaceutical Sciences, 4, 167
- 10.1001/archpsyc.1992.01820110045007 · DOI · Paper page
- 10.1016/S0006-8993(03)03252-9 · DOI
- 10.1016/j.ejphar.2003.11.072 · DOI
- 10.1054/jcaf.2002.125554 · doi:10.1054/jcaf.2002.125554
- 10.1093/alcalc/34.1.15 · DOI
- 10.1258/0004563011901064 · DOI · Paper page
- 10.1097/00007890-199401000-00002 · doi:10.1097/00007890-199401000-00002
- 10.1007/s11894-004-0029-y · DOI
- 10.1111/j.1365-2036.2004.01881.x · DOI · Paper page
- Wei Z. Z., 2004, Hepatobiliary and Pancreatic Diseases International, 3, 245
- 10.1097/01.TA.0000058119.60074.25 · DOI
- 10.1111/j.1399-6576.2004.00384.x · doi:10.1111/j.1399-6576.2004.00384.x
- 10.1152/ajpgi.00056.2004 · DOI · Paper page
Cited by
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867 · Cited by 764
Jørgensen, C. H., Pedersen, B., & Tønnesen, H. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01523.x · Cited by 366
Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087366 · Cited by 347
“Four of these compared disulfiram to naltrexone and to one other condition: to no disulfiram [13], to acamprosate [22,40], or to GHB [41].”
BackgroundGamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
Leone, M. A., Vigna-Taglianti, F., Avanzi, G., Brambilla, R., & Faggiano, F. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006266.pub2 · Cited by 163
Gamma hydroxybutyric acid (ghb) for the treatment of alcohol dependence: A review
Caputo, F., Vignoli, T., Maremmani, I., Bernardi, M., & Zoli, G. (2009) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph6061917 · Cited by 73
Metadata
- Authors
- Nava, F., Premi, S., Manzato, E., & Lucchini, A.
- Venue
- Journal of Psychoactive Drugs
- Publisher
- Informa UK Limited
- Published
- 2006-09-01
- Volume
- 38
- Issue
- 3
- Pages
- 211-217
- ISSN
- 0279-1072 (ISSN-L)
- 2159-9777
- OpenAlex
- W1998093226
- Cited by
- 39
- References
- 2
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparing Treatments of Alcoholism on Craving and Biochemical Measures of Alcohol Consumptions. https://app.cochat.ai/papers/10.1080/02791072.2006.10399846
- The paper
- Nava, F., Premi, S., Manzato, E., & Lucchini, A. (2006). Comparing Treatments of Alcoholism on Craving and Biochemical Measures of Alcohol Consumptions. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2006.10399846
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.